Corporate Profile
UG Healthcare Corporation Limited 优格医疗集团 (“UG Healthcare” or the “Company” and together with its subsidiaries, the “Group”) is an own brand manufacturer that markets and sells proprietary UNIGLOVES® branded products through its own established global downstream distribution network.
The Group owns and operates an extensive downstream network of distribution companies with a local presence in Europe, the United Kingdom, the USA, China, Africa, and South America, where it primarily markets and sells its proprietary UNIGLOVES® range of disposable examination gloves, and ancillary products. These disposable hand protection products are used across a diverse range of industries that require safety and cross-infection protection and high hygiene standards, as well as catering to different applications and preferences. The Group additionally enriches its product offerings with ancillary products comprising reusable gloves for users in the heavy industries, surgical, vinyl, and cleanroom disposable gloves, as well as non-glove hygiene and healthcare ancillary products, which are focused on infection control, hygiene and care, dental, and wound care.
The downstream distribution division is supported and complemented by the Group’s own upstream manufacturing division, manufacturing natural latex and nitrile disposable examination gloves under its UNIGLOVES® brand and third-party labels in its manufacturing facilities located in Seremban, Malaysia. The Group’s upstream manufacturing is certified by the British Standards Institution for ISO 9001:2015, ISO 13485:2016 and EN ISO 13485:2016, and in compliance with ISO 14971:2019 and EN ISO 14971:2019 for the scope of manufacture and supply of natural latex and nitrile latex examination gloves. The Group’s proprietary brand of products conforms to various international standards and requirements.
The Group has also strategically diversified into non-glove healthcare related businesses, including the joint development, management, and operation of active retirement homes in Malaysia.
UG Healthcare is listed on the Singapore Exchange Securities Trading Limited under stock code 8K7 since 8 December 2014.
Our Business Strategy
The Group’s strategy has always been to cultivate demand for our proprietary UNIGLOVES® range of disposable examination gloves through our downstream distribution companies. These strategically established distribution companies in both developed and developing countries have our local sales and marketing teams and distribution infrastructures (including local warehouses and logistics) as well as our direct customer base. The market demand for our UNIGLOVES® range of products, in turn, drives the production volume in our upstream manufacturing facilities in Malaysia. This approach allows the Group to manage the value chain seamlessly and efficiently, and build the OBM foundation.
The Group will continue to drive marketing campaigns to further entrench our market presence for our proprietary UNIGLOVES® branded products through our downstream distribution network. These campaigns focus on driving the marketing and sales of our established distribution companies in our key markets of Europe, the United Kingdom, the USA, China, Africa, and South America, and will be supported by these distribution companies which operate their own warehousing and logistics infrastructure.
We believe that our entrenched distribution infrastructure and network in both the developed and developing markets through hub and spoke strategy, will continue to drive growth for the Group as we broaden our product portfolio.
Leadership
The Board of Directors and the management team are committed to conduct our business activities in an economically, socially and environmentally responsible manner governed by high standards of internal controls and risk management practices to promote greater transparency and safeguard the interests of our stakeholders.
Mr. Wong Fook Choy Sunny joined the Board as the Non-Executive Chairman and Independent Director of the Company, Chairman of the Remuneration Committee and a member of the Audit and Nominating Committees on 2 December 2024.
A practising advocate and solicitor of the Singapore Supreme Court, Mr. Sunny Wong was co-founder and managing director of the legal firm Wong Tan & Molly Lim LLC, where he is currently a consultant.
Mr. Sunny Wong graduated from the National University of Singapore with a Bachelor of Laws (Honours).
Mr. Lee Jun Yih is the Joint CEO, Executive Director and Finance Director of the Company. He was appointed to the Board on 10 November 2014 and was last re-elected on 30 October 2023.
Mr. Lee is responsible for the Group’s overall operations and businesses, ensuring that the Group is operating in line with its vision and strategic direction. He is also responsible for the oversight and control of the Group’s overall accounting and finance function, which includes monitoring and coordinating the Group’s financial accounts, consolidation, and financial reporting.
Mr. Lee joined the Group in July 2011 and currently serves as a director on the boards of the Company’s subsidiaries and associated companies.
Mr. Lee graduated from Pembroke College, University of Cambridge with a Bachelor of Arts (Law) in June 2004. He began his career as a solicitor with Freshfields Bruckhaus Deringer, an international law firm, in its Hong Kong, London and Beijing offices in 2005 before joining JP Morgan, London, and UBS AG, Hong Kong as an analyst in the Investment Banking Division in August 2007 and April 2008, respectively. Thereafter, he joined AEGON Asset Management as an associate in January 2010.
He was admitted as a Solicitor of the High Court of the Hong Kong Special Administrative Region in September 2007.
Mr. Lee Jun Linn is the Joint CEO, Executive Director and Chief Operating Officer of the Company. He was appointed to the Board on 20 November 2014 and was last re-elected on 29 October 2024.
Mr. Lee is responsible for the Group’s overall operations and businesses, ensuring that the Group is operating in line with its vision and strategic direction. He is also responsible for directing and managing the Group’s sales, marketing, and distribution platforms, with an emphasis on formulating the Group’s marketing strategies and broadening its distribution network.
Starting his career with the Group as an Assistant General Manager of Unigloves Shanghai in April 2008, Mr. Lee rose through the ranks to become General Manager of Unigloves Shanghai in 2012. He was also appointed as a director of Unigloves Shanghai in July 2011 and a director of Unigloves (UK) Limited in April 2015.
Mr. Lee graduated from University College London with a Bachelor of Science (Economics) degree in August 2006 and subsequently obtained a Master of Science (International Management (China)) degree from the School of Oriental & African Studies in London in December 2007.
Mr. Lee Keck Keong is the Executive Director of the Company. He was appointed to the Board on 20 November 2014 and was last re-elected on 28 October 2022.
Mr. Lee has been instrumental in successfully leading the Group to become an established player in the gloves manufacturing industry. He also serves as a director on the boards of the Company’s subsidiaries and associated companies.
Mr. Lee graduated from the University of Surrey in 1977 with a degree in chemical engineering. Upon graduation, he started his career as a chemical engineer in a stateowned company. Thereafter, he entered into various business ventures in diverse industries, including mining, sawmilling, property development, and timber development.
Mr. Law Cheong Yan joined the Board as the Independent Director of the Company, Chairman of the Nominating Committee and a member of the Audit and Remuneration Committees on 2 December 2024.
Mr. Law is currently the Head of Strategy of Sing-Ed Corporation Pte. Ltd., where he oversees the strategic leadership and business development. He was formerly the Chief Financial Officer of Chip Eng Seng Corporation Ltd from August 2013 to January 2022.
Prior to rejoining Chip Eng Seng in 2013, Mr. Law spent more than nine years in the PRC and the US managing the businesses of several Singapore companies’ overseas subsidiaries. Mr Law was also the Group Financial Controller of Chip Eng Seng from June 1999 to February 2004, and an auditor with an international accounting firm from September 1995 to June 1999.
Mr. Law holds a Bachelor of Accountancy (Hons) degree from Nanyang Technological University, Singapore. He is also a member of ISCA and CPA Australia.
Ms. Ng Lee Eng is the Independent Director of the Company, Chairman of the Audit Committee and a member of the Nominating and Remuneration Committees. She was appointed to the Board on 1 December 2023 and was last re-elected on 29 October 2024.
Ms. Ng has more than 15 years of experience in finance, accounting and human resource during her role as Finance Manager at EagleBurgmann KE Pte Ltd. As a key member of the management team, she had oversight over financial and management reporting, internal controls, tax and human resource functions.
She is graduated with a Bachelor of Business in Accountancy from the Royal Melbourne Institute of Technology. She is also a member of the Singapore Institute of Directors and associate member of the Institute of Singapore Chartered Accountants.
Ms. Ng is currently an independent director of Medi Lifestyle Limited listed on the Catalist Board of SGX-ST.